NUCALA
NUCALA
Discontinued
DIN Number
02449781
Drug Class
Human
Market Date
Mar 14, 2016
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02449781
AIG Number0157630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
R03DX09 MEPOLIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification90:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MEPOLIZUMABActive
Strength: 100 MG / VIAL
Monograph: MEPOLIZUMAB